Cross-Regional Pitch & Match session

12 Jun 2025 | Park Inn by Radisson Leuven -

Filip Delport

CTO

Vixen Bio

Gent, Belgium

4 profile visitsOn-siteNon-member

At Vixen Bio we derisk development and clinical trials early by fast, custom bio-analytical services in clinically relevant conditions.

My organisation

Vixen Bio

Vixen Bio

R&D Services

Gent, Belgium

At Vixen Bio, we empower the world of antibodies - therapeutics and diagnostics - with cutting-edge bioanalytical services tailored for the pharmaceutical and clinical development sectors. We derisk development and clinical trials early by fast, custom measurements in clinically relevant conditions. With deep expertise in immunology and advanced analytics, we specialize in supporting faster, more informed, and safer drug and diagnostic development. Our mission is to help CRO’s, pharma and biotech companies accelerate innovation—from discovery through clinical trials—by delivering precise, immune response–driven insights that inform better design, production, dosing, earlier detection of adverse effects, and more personalized treatment strategies. We’re not just a service provider—we’re a partner in innovation. Whether it's navigating complex biologics design or optimizing clinical trial outcomes, Vixen Bio is committed to making precision medicine a reality.
Read more

About me

As a scientist and entrepreneur, I’ve always been driven by the intersection of innovation and real-world application. My career began with a PhD at KU Leuven, where I focused on developing a novel biosensor platform—an experience that sparked both deep technical expertise and a passion for translating research into impactful solutions.

During my PhD, I co-founded Encert, a small company providing energy certificates, gaining early hands-on experience in business operations and client services. This blend of science and entrepreneurship eventually led to the founding of a spin-off company in 2019, centered on the commercial potential of the biosensor technology developed during my doctoral work.

Currently, I serve as Chief Technology Officer at Vixen Bio, a dynamic service provider specializing in biomolecular interaction analysis. We support therapeutic and diagnostic development through cutting-edge biophysical characterization, enabling faster and more informed decision-making for our partners in biotech and pharma.

With a strong foundation in biosensor R&D, entrepreneurial drive, and leadership in biotech services, I’m passionate about bridging the gap between advanced science and industry needs.

Social media

Skills

  • immunoassays
  • Assay Development

Interests

  • immunogenicity
  • functional assays
  • Biomarkers

Marketplace (1)